The global bilirubin meters market was valued at $1.2 billion in 2023, and is projected to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
The global newborn screening instruments market was valued at $0.6 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.1% from 2024 to 2033.
